ID Week

2 stories · following the connections

Business

Summit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploratory Phase 2 Clinical Trial at ID Week 2017

By Nasdaq OMXOct 9, 2017, 11:00 AM UTC

Business

T2 Biosystems Announces Presentations at IDWeek 2016

By Nasdaq OMXOct 13, 2016, 12:00 PM UTC